Sign In
Buy BAYRY
$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
Bayer: Significant Upside Despite A Challenging Environment
10:29am, Tuesday, 18'th Oct 2022
European stocks - including Bayer - we punished in the last few months, and the potential energy crisis could be a reason. But Bayer is reporting solid quarterly results and could increase its fiscal
7 Under-$20 Sleeper Stocks to Buy Before Wall Street Wakes Up
01:49pm, Tuesday, 27'th Sep 2022
In arguably most cases, investors should concentrate the bulk of their portfolio on high-quality names, irrespective of catchy marketing schemes like under-$20 sleeper stocks to buy. Usually, comfort
Bayer Rumored to Be Bidding Early Goodbye to CEO
03:37pm, Wednesday, 14'th Sep 2022
Professional teams are well known for “eating” bad contracts, and now it looks like German pharmaceutical company Bayer AG ( XTER:BAYN , Financial) is following suit. Rumors abound that CEO Werner
U.S. says Bayer to pay $40 million to resolve whistleblower lawsuits
12:28pm, Friday, 02'nd Sep 2022
Bayer AG and some of its subsidiaries agreed to pay $40 million to settle claims over its alleged use of kickbacks and false statements related to the drugs Trasylol, Avelox and Baycol, the U.S. Depar
Bristol Myers Squibb, Bayer Stocks Hit The Deck On Blood Thinner Flops
12:24pm, Monday, 29'th Aug 2022
Bristol Myers and Johnson & Johnson's blood thinner fell short of expectations in stroke patients, leading BMY stock to crumble on Monday. The post Bristol Myers Squibb, Bayer Stocks Hit The Deck On B
Bristol-Myers, J&J and Bayer Presenting Key Study Results at Heart Meeting
10:35am, Monday, 29'th Aug 2022
Investors should keep an eye on developments at the European Society of Cardiology meeting, which is underway in Barcelona. News about a new type of heart drug being tested by Bristol-Myers Squibb Co.
Bayer Aktiengesellschaft (BAYRY) is a Top-Ranked Value Stock: Should You Buy?
11:18am, Thursday, 25'th Aug 2022
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Ray Dalio's Bridgewater cuts European short bet to under $1 billion
04:46am, Thursday, 18'th Aug 2022
Bridgewater Associates, one of the biggest hedge funds in the world, has seemingly walked away from its big short bet
Plaintiff in first Zantac lawsuit set for trial drops case
02:54pm, Wednesday, 17'th Aug 2022
The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according to his attorney and drugmakers named as defendants.
Bayer says it will continue supplying Russia with agricultural inputs
12:22pm, Monday, 15'th Aug 2022
Germany's Bayer said it has decided to continue supplying Russia with essential agricultural inputs, reversing course from comments made in March that supplies for 2023 would be contingent on Russia s
Bayer launches sustainable agriculture hub to connect U.S. farmers, food and fuel makers
05:04am, Monday, 15'th Aug 2022
Agricultural seeds and chemicals maker Bayer AG on Monday launched a digital farming platform that it says will help U.S. growers enact environmentally friendly practices and connect them with compani
Bayer welcomes ruling against BASF claim on seed businesses
05:29am, Friday, 12'th Aug 2022
Bayer on Friday welcomed a decision by an arbitration court to dismiss a claim by BASF that it overpaid for assets sold by Bayer to secure antitrust clearance for the takeover of Monsanto.
Mexican President says Bayer interested in continuing to invest in country
02:06pm, Tuesday, 09'th Aug 2022
Mexican President Andres Manuel Lopez Obrador said on Tuesday that the chief executive of German diversified group Bayer Werner Baumann said the firm is interested in continuing to invest in Mexico in
Bayer: Bullish Thesis Confirmed
05:08pm, Thursday, 04'th Aug 2022
In Q2 2022, Bayer delivered strong results across all of the company's divisions. Bayer generated revenues of EUR 12.8 billion (+9.6% year over year), and EBITDA before special items jumped by more th
Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q2 2022 Results - Earnings Call Transcript
02:44pm, Thursday, 04'th Aug 2022
Bayer Aktiengesellschaft (OTCPK:BAYZF) Q2 2022 Results Conference Call August 4, 2022 9:00 AM ET Company Participants Oliver Maier - Head, IR Werner Baumann - CEO Wolfgang Nickl - CFO Rodrigo Santos -
